?Effect of restrictive fluid management on the outcome of transient tachypnea of the newborn at ahvaz Imam Khomeini hospital

Not Applicable

• Conditions: transient tachypnea of the newborn.; Respiratory distress of newborn

• Registration Number: IRCT2012111111432N1
• Lead Sponsor: Ahvaz,Jundishapur University of Medical Siences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

inclusion criteria: neonate with in 34-0/7to 41-6/7 weeks age with: tachypnoea (RR>60) ;standing on tachypnea at least for 12 hrs; feature of CXR at least for one of these: prominent pulmonary hilus, increase thickness of lobar fisher due to accumulation of fluid, hilar congestion of both lung,flattening of diaphragm,increase AP diameter of chest exclusion criteria:neonate with congenital anomaly;systemic sepsis; mecunium aspiration; RDS; IUGR; fetal distress history; pneomonitis;congenital heart disease; DIC; multi organ failure; hypocalcemia; hypoglycemia; polycytemia; Na>150; Bun>20; K>5; Bill>15; urine out put<1cc/kg/hr

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of oxygen requirement. Timepoint: during intervention. Method of measurement: hours.;Duration of CPAP requirement. Timepoint: during intervention. Method of measurement: hours.;Duration of VENTILATOR requirement. Timepoint: during intervention. Method of measurement: hours.;Hospitalized duration. Timepoint: during intervention. Method of measurement: days.

Secondary Outcome Measures

Name	Time	Method
rine out put. Timepoint: during intervention. Method of measurement: cc/kg/hr.;Serum BUN , CREATININ. Timepoint: during intervention. Method of measurement: serum sampling.;Serum K , Na. Timepoint: during intervention. Method of measurement: serum sampling.;Serum bilirubin. Timepoint: during intervention. Method of measurement: serum sampling.;Specific gravity of urine. Timepoint: during intervention. Method of measurement: with refractometer.;ABG. Timepoint: during intervention. Method of measurement: artery sampling.